Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Cost of Revenue (2017 - 2020)

Updated

Sigyn Therapeutics' Cost of Revenue was $1,799 in Q3 2020, down 77.5% from $8,010 a year earlier.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Cost of Revenue (2017 - 2020) Analysis & Trends

On a trailing twelve-month basis, Sigyn Therapeutics' Cost of Revenue was $3,637 through Sep 30, 2020, down 89.3% year-over-year; for FY2019, it came in at $35,665, up 267.2% from FY2018.

  • Cost of Revenue shows a three-year compound annual growth rate of -63.2% (FY2016 to FY2019).
  • In earlier years, Cost of Revenue was $9,712 in FY2018 (-54.7%), $21,431 in FY2017 and $717,334 in FY2016.
  • Quarterly Cost of Revenue has moved between -$351,239 (Q4 2017) and $185,270 (Q2 2017) over five years.
  • The year-over-year decline in Cost of Revenue has ranged between 4.5% (Q1 2019) and 97.2% (Q1 2020) over the last five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 1,799.00
Mar 31, 2020 263.00
Dec 31, 2019 1,575.00
Sep 30, 2019 8,010.00
Jun 30, 2019 16,830.00
Mar 31, 2019 9,250.00
Sep 30, 2018 12,660.00
Jun 30, 2018 71,002.00
Mar 31, 2018 9,681.00
Dec 31, 2017 -351,239.00
Sep 30, 2017 98,465.00
Jun 30, 2017 185,270.00
Mar 31, 2017 75,998.00
API Access

Sigyn Therapeutics, Inc. Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SIGY&period=max&api_key=YOUR_API_KEY